-
American Nobel laureate in medicine hopes to illuminate the brain
-
Tens of thousands expected in Paris for high school protests
-
Trump approves firing squad for convicted US military base shooter
-
AI borrowing binge rattles US markets
-
Grappling with 'homework scams,' US universities shun AI detectors
-
Young Canadians sue government over alleged climate failures
-
Separatists win Quebec election in test for Canada PM
-
White Sox down Guardians to take 2-0 series lead
-
Leaders visit Pacific atoll at frontline of climate change
-
NHL record-breaker Ovechkin says current season will be his last
-
Yemen's Houthis claim striking Riyadh airport, other Saudi sites
-
France roar back in Nations League as Italy beat Turkey
-
Best-selling British author Jeffrey Archer dies aged 86
-
Messi readies for final farewell in Argentina send-off
-
Military plane crash kills 32 in Nigeria
-
Esposito seals Italy win over Turkey in Nations League
-
Olise powers France to win over Belgium in Nations League
-
Russia downplays plague reports as Trump offers US help
-
High-flying Blazy turns to birdlife at Chanel
-
Trump says US moved bombers from UK base after 'threats'
-
Riyadh's allies pledge troops as Yemen, Saudi Arabia attack Houthis
-
Brazilian stocks surge to record after Bolsonaro election lead
-
Clashes erupt outside Kosovo parliament over war crimes court
-
Leaders to visit Pacific atoll at frontline of climate change
-
Milan's Saelemaekers suffers ankle setback, faces lengthy spell out
-
ICC gives more details about arrest warrants for Taliban ministers
-
Rubio arrives in Iceland to push for greater US presence in Arctic
-
Nigeria's Tinubu confirms 32 dead after military plane crash
-
Putin allows Italy's UniCredit to sell part of Russian business
-
'Reckless' AI firms can't control models, says whistleblower
-
Djokovic into China Open final as Medvedev out for hitting fan with ball
-
Switching on brain cells: the Nobel-winning science of optogenetics
-
ICC unseals arrest warrants for Taliban education ministers
-
Quebec votes as separatist surge poses test for Canada PM
-
Modric hopes fans back Croatia against Spain after England shame
-
Euro slides as concerns about French debt mount
-
Bolsonaro rides right-wing surge into Brazil's election runoff
-
Former Trump press secretary Leavitt joins Fox News
-
Turkey blocks X account of British reporter
-
Djokovic advances to China Open final as Medvedev out for hitting fan with ball
-
Ukraine says using AI robot guns to shoot down new Russian drones
-
Disgraced former US House speaker dies at 84
-
At Oct 7 memorial, Netanyahu says will be no Hamas rule in Gaza
-
Euro slides as worries about French debt grow
-
Ukraine blames Russia for deadly sinking of Turkish ship in Black Sea
-
US withdraws all bomber aircraft from UK airbase
-
UN rights council slams Taliban's 'oppression' of women
-
Drone hits Ethiopia IDP camp as fears grow of regional war
-
Norway eyes partial ban of smart glasses
-
US-German trio wins medicine Nobel for illuminating the brain
Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for "Competing for the Cure" Conference on Biopharmaceutical Ecosystems
PARIS, FR / ACCESS Newswire / September 28, 2026 / On October 29-30, 2026, the Berkeley Policy Institute's Eira Initiative will host a major international conference titled "Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems" at the Maison de l'Amérique Latine in Paris.
The two-day event will bring together top economists, legal scholars, industry leaders, and policy architects in the life sciences to present ground-breaking empirical and policy research on how intellectual property rights, pricing controls, artificial intelligence, and trade frameworks impact biopharmaceutical innovation worldwide.
The conference takes place at a critical juncture for the life sciences, addressing international trade developments, patent reforms, pricing policy, ecosystem competition, and the evolving role of IP assets across major biopharma markets - including Europe, China, India, Japan, and the United States.
High-Level Keynotes & Policy Fireside Chat
The conference program features keynote addresses by Mark Schankerman (London School of Economics) and Yann Ménière (Chief Economist, European Patent Office).
A headline Fireside Chat with Nicolas Petit (European University Institute), Kamil Kiljanski (European Commission), and Hon. Peter-Anthony Pappas (US International Trade Commission), moderated by Bowman Heiden (Gothenburg Univ. & UC Berkeley), will translate empirical findings into actionable policy strategies.
Key Conference Sessions & Featured Research:
- Day 1, Panel 1: IP Rights and Biopharmaceutical Ecosystem Design Features research on IP-backed collateral lending post-2022 ("The Great Biotech Reset") by Christine McDaniel (World Bank) and network mapping of pharma innovation systems by Angelos Stenimachitis (Univ. of Essex / Compass Lexecon), commented by Mark Schankerman (LSE).
- Day 1, Panel 2: Patent Term, Tax Incentives, and Biopharmaceutical Innovation Features findings on Supplementary Protection Certificate eligibility by Satyaki Chakravarty (Università Cattolica), Australian patent pendency dynamics by Gaétan de Rassenfosse (EPFL), and the impact of orphan drug tax credits by Simona Gamba (Univ. of Milan) and Laura Magazzini (Sant'Anna), commented by Margaret Kyle (Mines Paris - PSL, CEDP).
- Day 1, Panel 3: Reinvigorating European & Global Ecosystems Explores structural shifts beyond the "blockbuster" drug development model by Andrea Dugo & Oscar Guinea (ECIPE), open strategic health sovereignty by Timo Minssen & Gabriela Maria Lenarczyk (Univ. of Copenhagen), and foreign R&D burden-sharing in trade deals by Alden Abbott & Satya Marar (Mercatus Center), commented by David Bosco (Univ. Aix-Marseille).
- Day 1, Panel 4: Price Controls, Pricing Policy, and Biopharmaceutical Innovation Features analysis on European price controls by Duane Schulthess (Vital Transformation), international price control comparisons by Stephen Ezell & Sandra Barbosu (ITIF), and the impact of value-based pricing on drug development by Katharina Blankart (Bern Univ. of Applied Sciences), commented by Jamie Simpson (C4IP).
- Day 2, Panel 1: IP Rights and Global Biopharmaceutical Markets Examines pharmaceutical global value chains by Walter Park (American Univ.) and the development of the Indian pharma ecosystem by Chirantan Chatterjee (Univ. of Sussex) & Aniruddh Bhaskaran (Carnegie Mellon Univ.), commented by Nikolaus Thumm (OECD).
- Day 2, Panel 2: China's Biopharmaceutical Ecosystem: Policy Insights and Global Implications Analyzes Chinese IP and other reforms in biopharma by Can Huang (Zhejiang Univ.), Chinese IP policy evolution by Mark Cohen (UC Berkeley), and China's global biopharma rise by Dan Prud'homme (Florida Intl. Univ.) & Tao Bai (Univ. of Queensland), commented by Sharon Belenzon (Duke Univ.) and Jonathan Barnett (USC).
- Day 2, Panel 3: Artificial Intelligence, Pandemics, and Biopharmaceutical Drug Development Examines patent strategy considerations for AI drug discovery by Laura Fè (Murgitroyd) & Alice Norga, and the impact of public health outbreaks on innovation by Xixi Hu (UBC), commented by Jonathan Barnett (USC).
Event Details & Registration
- Dates: October 29-30, 2026
- Venue: Maison de l'Amérique Latine, 217 Bd Saint-Germain, 75007 Paris, France
- Format: In-Person Conference
- Registration Link: In-Person Conference Registration
To view the complete agenda, speaker line-up, and paper abstracts, please visit https://eirainitiative.org/events/
FOR MORE INFORMATION, CONTACT:
EIRA Initiative / Berkeley Policy Institute
Email: [email protected]
Website: https://eirainitiative.org/events/
SOURCE: EIRA Initiative
View the original press release on ACCESS Newswire
H.Gonzales--AT